G01N33/483

System and method for non-invasive embryo sexing

Disclosed is a system and device for determining sex of an embryo utilizing a non-invasive grading of early stage embryos (pre-hatching) based upon specific gravity, density and/or estimated weight. The device comprises a drop chamber having a lumen, capable of assessing characteristics of at least one embryo while descending. The system allows 100% recovery of embryos. A processor is further capable of performing assessment of the embryos. The disclosed system supports a wide variety of scenarios for human and animal reproductive technologies and related products and services.

System and method for non-invasive embryo sexing

Disclosed is a system and device for determining sex of an embryo utilizing a non-invasive grading of early stage embryos (pre-hatching) based upon specific gravity, density and/or estimated weight. The device comprises a drop chamber having a lumen, capable of assessing characteristics of at least one embryo while descending. The system allows 100% recovery of embryos. A processor is further capable of performing assessment of the embryos. The disclosed system supports a wide variety of scenarios for human and animal reproductive technologies and related products and services.

FLUIDIC DEVICE FOR QUANTIFYING THE DYNAMIC PERMEABILITY AND HYDRAULIC CONDUCTIVITIY OF LIVING TISSUE LAYERS

Systems and methods for measuring dynamic hydraulic conductivity and permeability associated with a cell layer are disclosed. Some systems include a microfluidic device, one or more working-fluid reservoirs, and one or more fluid-resistance element. The microfluidic device includes a first microchannel, a second microchannel, and a barrier therebetween. The barrier includes a cell layer adhered thereto. The working fluids are delivered to the microfluidic device. The fluid-resistance elements are coupled to one or more of the fluid paths and provide fluidic resistance to cause a pressure drop across the fluid-resistance elements. Mass transfer occurs between the first microchannel and the second microchannel, which is indicative of the hydraulic conductivity and/or dynamic permeability associated with the cells.

Magnetic Lensing For Beta Emission Imaging
20180011159 · 2018-01-11 ·

In beta emission imaging, magnetic lensing allows a lower resolution detector to detect the spatial distribution of emissions at a higher resolution. The sample is placed in a magnetic field with field lines at a given density, and the detector is placed away from the sample where the magnet field lines diverge, resulting in a lesser density. Since the beta emissions travel along the field lines, the divergence of the field lines from the sample to the detector result in lensing or magnification. Using positron attenuation tomography to detect annihilation in the detector allows for correction due to self-absorption by the sample. The correction and lensing are used together or may be used independently.

MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION

Described herein are reagents and methods for improving signal in imaging mass cytometry. Aspects include mass tags with a large number of labeling atoms, chemical modifications to mass tags and additional reagents to reduce background and/or maintain target binding of mass tagged specific binding partners (SBPs), and schemes for associating a plurality of mass tags with a single SBP. As such, embodiments include any combination of one or more reagents and their use. The reagents, kits and methods herein may be used for mass cytometry, including imaging mass cytometry. In some aspects, reagents, kits or methods may be used for delivery of a large number of radioisotopes to a target analyte, for example for therapeutic use or radiometric detection. In certain aspects, only non-radioactive isotopes may be used for mass cytometry.

MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION

Described herein are reagents and methods for improving signal in imaging mass cytometry. Aspects include mass tags with a large number of labeling atoms, chemical modifications to mass tags and additional reagents to reduce background and/or maintain target binding of mass tagged specific binding partners (SBPs), and schemes for associating a plurality of mass tags with a single SBP. As such, embodiments include any combination of one or more reagents and their use. The reagents, kits and methods herein may be used for mass cytometry, including imaging mass cytometry. In some aspects, reagents, kits or methods may be used for delivery of a large number of radioisotopes to a target analyte, for example for therapeutic use or radiometric detection. In certain aspects, only non-radioactive isotopes may be used for mass cytometry.

Sample container for stabilizing and aligning excised biological tissue samples for ex vivo analysis

Embodiments described herein relate to an apparatus for positioning and securing an excised biological tissue specimen for imaging and analysis. In some embodiments, an apparatus includes a sample bag defining an inner volume configured to receive a biological tissue sample, and a sealing member coupled to the sample bag. An imaging window is disposed and configured to be placed in contact with at least a portion of the biological tissue sample, and a positioning member is coupled to the imaging window and is configured to be disposed against the sealing member to substantially seal the inner volume. The positioning member includes a vacuum port disposed and configured to be aligned with a vacuum source to withdraw air from the inner volume of the sample bag.

Method for digitally generating scores for multiple diagnostic tests from tissue assayed with a single test

One type of tissue-based assay, the companion diagnostic (“CDx”) allows for the identification of individuals within a larger patient population who are more likely to respond to a therapy. The CDx paradigm typically applies to drugs that target a specific gene product or biologic pathway involving a gene product of interest. It is possible, especially for popular therapeutic targets, for multiple drugs and multiple associated CDx to be developed for a single gene product or biologic pathway involving the gene product. Currently, each of these similar CDx must be applied to identify the best therapy. The present invention can determine the outcome of one CDx using an image of a tissue section used for another CDx. Using a single tissue section and a single CDx, it becomes possible to obtain the outcome of multiple, related CDx.

CELL AGGREGATE INTERNAL PREDICTION METHOD, COMPUTER READABLE MEDIUM, AND IMAGE PROCESSING DEVICE
20230026189 · 2023-01-26 · ·

An internal prediction method includes acquiring an image of a cell aggregate, calculating a feature amount related to a shape of the cell aggregate on the basis of the image, and outputting structure information related to an internal structure of the cell aggregate on the basis of the feature amount.

EXCREMENT ANALYSIS APPARATUS, ANALYSIS SYSTEM, SERVER APPARATUS, ANALYSIS METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM

An excrement analysis apparatus includes an inputter, a memory, a first analyzer, and a second analyzer. The inputter inputs imaging data captured by an image capture apparatus installed in such a way as to include, in a capturing range, an excretion range of excrement in a toilet bowl of a toilet. The memory temporarily holds the imaging data input by the inputter. The first analyzer analyzes first analysis target data being the imaging data input by the inputter, and outputs notification information to an observer who observes a user of the toilet. The second analyzer analyzes second analysis target data being the imaging data that is input by the inputter and temporarily held by the memory, and outputs detailed information indicating a content of excretion.